Literature DB >> 2170134

Hepatitis C virus infection in sexually promiscuous groups.

A Sánchez-Quijano1, C Rey, I Aguado, J A Pineda, M Perez-Romero, Y Torres, M Leal, E Lissen.   

Abstract

As there is insufficient data available on the spread of hepatitis C virus (HCV) infection by sexual transmission, the prevalence of anti-HCV was determined in several sexually promiscuous groups (78 female prostitutes, 55 clients of prostitutes and 146 homosexual men) who denied intravenous drug abuse. The overall HCV infection rate was much higher in the sexually promiscuous groups (8.97%, 16.36% and 5.48% respectively) than in voluntary blood donors (0.48%), suggesting that HCV infection can be transmitted by sexual intercourse. Consequently, promiscuity may be a risk factor for this infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170134     DOI: 10.1007/BF01967218

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Hepatitis C: and miles to go before we sleep.

Authors:  M J Alter; R E Sampliner
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

3.  Evidence for viral hepatitis other than type A or type B among persons in Costa Rica.

Authors:  V M Villarejos; K A Visoná; C A Eduarte; P J Provost; M R Hilleman
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

4.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

5.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

6.  Non-A, non-B hepatitis in West London.

Authors:  L J Farrow; J S Stewart; H Stern; R E Clifford; H G Smith; A J Zuckerman
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

7.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 8.  Non-A, non-B viral hepatitis.

Authors:  P V Holland; H J Alter
Journal:  Hum Pathol       Date:  1981-12       Impact factor: 3.466

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

  9 in total
  3 in total

1.  Association between hepatitis C virus seroreactivity and HIV infection in non-intravenous drug abusing prostitutes.

Authors:  J A Pineda; A Rivero; C Rey; J Hernández-Quero; A Vergara; J Muñoz; I Aguado; J Santos; R Torronteras; J A Gallardo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

2.  Infection by hepatitis B and C virus in non-intravenous drug using female prostitutes in Spain.

Authors:  A Orduña; M A Bratos; P Gutierrez; A Almaraz; J M Eiros; J F Martín; J M Gonzalez; A Caro-Patón; A Rodríguez-Torres
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

3.  Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases.

Authors:  E Lissen; H J Alter; M A Abad; Y Torres; M Pérez-Romero; M Leal; J A Pineda; R Torronteras; A Sánchez-Quijano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.